Medicine RSS Search Engine

Cancer & Oncology News Cancer & Oncology OPML fileThis is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. Cancer & Oncology News RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 11.

HER2 Status Best Predicts Benefit of Anti-HER2 Therapy
SAN ANTONIO (IMNG) - A variety of biomarkers failed to improve on the results of tumor HER2 status for predicting the benefits of therapy targeting HER2 signaling, based on an analysis of data from the...
Source: OncologySTAT Latest News - January 25, 2013 Category: Cancer & Oncology Source Type: news

Resecting Residual Gastrointestinal Stromal Tumors Improved Survival
SAN FRANCISCO (IMNG) - Surgically removing residual gastrointestinal stromal tumors in patients who respond to imatinib therapy significantly increased time to tumor progression to 88 months, compared...
Source: OncologySTAT Latest News - January 25, 2013 Category: Cancer & Oncology Source Type: news

Smoking continues to threaten US public health
Research published in The New England Journal of Medicine shows that disease and mortality due to smoking have continually increased over the past 50 years in the USA.
Source: MedWire News - Oncology - January 25, 2013 Category: Cancer & Oncology Source Type: news

A 45-Year-Old Woman With an Incidental Finding on MRI
A healthy 45-year-old woman undergoes an MRI for persistent headaches. The headaches resolve with conservative management. However, there is an incidental finding on the MRI of a homogeneously enhancing mass in the right jugular foramen. What is your diagnosis?
Source: Cancer Network - January 25, 2013 Category: Cancer & Oncology Source Type: news

Gleevec’s Latest Approval is for Pediatric Cancer
Drug blocks proteins that fuel cancer-cell development
Source: The Doctors Lounge - Oncology - January 25, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pediatrics, Pharmacy, FDA Approvals, Source Type: news

FDA Approves New Use for Cancer Drug
The U.S. FDA approved a new use for Novartis AG's cancer drug, Gleevec, in children.
Source: WSJ.com: Health - January 25, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

High doses of folic acid not tied to cancer risk
NEW YORK (Reuters Health) - According to a new analysis, people taking high doses of the B vitamin folic acid are not at an increased risk of cancer - easing some concern about possible side effects of national fortification programs.
Source: Reuters: Health - January 25, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

High Doses of Folic Acid Not Tied to Cancer Risk
According to a new analysis, people taking high doses of the B vitamin folic acid are not at an increased risk of cancer - easing some concern about possible side effects of national fortification programs.Source: Reuters Health Related MedlinePlus Pages: Cancer, Folic Acid
Source: MedlinePlus Health News - January 25, 2013 Category: Consumer Health News Source Type: news

Nuclear Oncology
Pathophysiology and Clinical ApplicationsNuclear Oncology: Pathophysiology and Clinical Applications is a comprehensive textbook covering the increasing role of radionuclide-based technologies in the management of oncologic patients, with disease-oriented chapters giving a detailed overview of current indications and developments. Topics covered include instrumentation, physics, radiobiology, radioguided surgery, and radionuclide ...
Source: Springer Medicine titles - January 25, 2013 Category: Databases & Libraries Tags: Nuclear Medicine Source Type: news

Emotional stress reduces effectiveness of prostate cancer therapies in animal model
Not surprisingly, a cancer diagnosis creates stress. And patients with prostate cancer show higher levels of anxiety compared to other cancer patients. A new study indicates that stress is not just an emotional side effect of the diagnosis; it also can reduce the effectiveness of prostate cancer drugs and accelerate the development of prostate cancer.
Source: ScienceDaily Headlines - January 25, 2013 Category: Science Source Type: news

Breast Cancer Screening Questioned Yet AgainBreast Cancer Screening Questioned Yet Again
After a fierce debate, a specially commissioned independent review in the United Kingdom was to lay the controversy to rest, but the questioning continues. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - January 25, 2013 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Quitting Smoking Before Cancer Surgery Best, Study Finds
Experts urge stopping at time of diagnosis, but quitting any time is healthy Source: HealthDay Related MedlinePlus Pages: Cancer, Quitting Smoking, Surgery
Source: MedlinePlus Health News - January 25, 2013 Category: Consumer Health News Source Type: news

Folic Acid Supplements Not Linked To Increased Cancer Risk
Folic acid supplements are not liked to an increased cancer risk when taken for up to 5 years. The finding came from new research which looked at data on nearly 50,000 people and was published in The Lancet. Short-term use of folic acid supplements is unlikely to considerably increase or decrease overall cancer risk and has little impact on the risk of developing any specific cancers, such as prostate, colon, lung, and breast...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Panel Ups Ante in PC Screening ControversyPanel Ups Ante in PC Screening Controversy
Dr. Gerald Chodak discusses new guidance from a California expert panel regarding prostate cancer screening, along with implications for practicing urologists. Medscape Urology
Source: Medscape Today Headlines - January 25, 2013 Category: Consumer Health News Tags: Urology Commentary Source Type: news

ASCO GI: CT unnecessary for staging early gastric cancer
SAN FRANCISCO - CT is unnecessary for staging gastric cancer owing to its poor (more)
Source: AuntMinnie.com Headlines - January 25, 2013 Category: Radiology Source Type: news

Folic Acid-Cancer Debate Continues (CME/CE)
(MedPage Today) -- Folic acid supplementation had no statistically significant effect on the incidence of cancer over the course of 5 years, a meta-analysis found, but questions remain.
Source: MedPage Today Hematology/Oncology - January 25, 2013 Category: Hematology Source Type: news

P53 mutation hinders cancer treatment response
Scientists have discovered the workings of the gene that has been hindering treatment response in cancer patients. This discovery was made after five years of studying the mutant form of the p53 gene, the major tumor suppressor in humans, which is generally found mutated in over 50 percent of all type of human cancers.
Source: ScienceDaily Headlines - January 25, 2013 Category: Science Source Type: news

Tumor cells engineer acidity to drive cell invasion
Researchers have investigated the acidity in solid tumors to determine if pH levels play a role in cancer cell invasion in surrounding tissues. They found that an acidic microenvironment can drive cancer cells to spread and propose that neutralizing pH would inhibit further invasion, providing a therapeutic opportunity to slow the progression of cancers.
Source: ScienceDaily Headlines - January 25, 2013 Category: Science Source Type: news

Gene mutation immortalizes malignant melanoma
Scientists have discovered a previously unknown genetic cause of malignant melanoma: A gene mutation that leads to overactive telomerase, the so-called 'immortality enzyme.'
Source: ScienceDaily Headlines - January 25, 2013 Category: Science Source Type: news

New method identifies genes that can predict prognoses of cancer patients
Scientists report that a new algorithm can more accurately identify gene sets that could more closely predict prognoses of cancer patients.
Source: ScienceDaily Headlines - January 25, 2013 Category: Science Source Type: news

Folic Acid Supplements Don’t Affect Cancer Risk, Review Finds
This should reassure those in U.S., other countries where supplementation is common, researcher says
Source: The Doctors Lounge - Oncology - January 25, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Obstetrics, Nutrition, News, Source Type: news

The Smoking Gun: Women Catch Up To Men On Lung Cancer Risk
The horror that was the Sandy Hook massacre has finally precipitated a substantive call-to-action in the United States -- a debate about who should have what kind of gun. Mass shootings aside, guns have reliably killed around 30,000 US citizens each year for the past decade.
Source: Forbes.com Healthcare News - January 25, 2013 Category: Pharmaceuticals Authors: David Kroll Source Type: news

Supreme Court to Hear Challenge to BRCA Gene Patents AgainSupreme Court to Hear Challenge to BRCA Gene Patents Again
After a long journey through the courts, the challenge to patents on the BRCA1 and 2 genes will be heard by the US Supreme Court. Medscape Medical News
Source: Medscape Today Headlines - January 25, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Use IHC Assay First for HER2 in Esophageal Ca
SAN FRANCISCO (MedPage Today) -- Immunohistochemistry to assess HER2 status in esophageal cancer showed good sensitivity and specificity, suggesting potential to reserve a more costly test for indeterminate IHC results, according to a study reported here.
Source: MedPage Today Primary Care - January 25, 2013 Category: Primary Care Source Type: news

Namibia: Tyres for Cancer
[Namibia Economist]The Cancer Association of Namibia (CAN) this week received a donation of N$67,720 from Quality Tyres Namibia. Quality Tyres contacted the association in October last year to raise funds for prostrate cancer awareness, as part of the Movember Campaign.
Source: AllAfrica News: Health and Medicine - January 25, 2013 Category: African Health Source Type: news

Survival advantage of patients with advanced pancreatic cancer(1)
Celgene UK and Ireland, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that its phase III clinical trial of ABRAXANE® (nab-paclitaxel) in combination with gemcitabine in treatment-naïve patients with metastatic pancreatic cancer demonstrated a statistically significant improvement in overall survival compared to patients receiving gemcitabine alone.
Source: Pharmacy Europe - January 25, 2013 Category: Drugs & Pharmacology Source Type: news

ASCO GI: Docetaxel for Advanced Esophagogastric Adenocarcinoma Improves Survival in Second-Line Setting
Adding the chemotherapy docetaxel to active symptom control in advanced esophagogastric adenocarcinoma improves survival of patients. These are the results of the phase III COUGAR-02 trial.
Source: Cancer Network - January 25, 2013 Category: Cancer & Oncology Source Type: news

Too Many Mastectomies?
My friend needs surgery for "early" breast cancer. She wants to have both breasts removed because she wants to take no chances that cancer will occur in the healthy breast. Does this make sense?
Source: Dr. Weil Q and A - January 25, 2013 Category: Consumer Health Advice Source Type: news

Novel Surgical Technique Being Tested For Uterine, Cervical Cancer Patients
A technique initially used to spare breast tissue during surgery is being researched by an Indiana University School of Medicine physician to improve prognosis, reduce complications and spare lymph nodes in women with gynecological cancer. Emma Rossi, M.D., assistant professor of obstetrics and gynecology at the IU School of Medicine and a physician researcher at the Indiana University Melvin and Bren Simon Cancer Center, was the first to describe a novel technique for sentinel lymph node mapping in uterine and cervical cancer patients...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Cervical Cancer-Causing Virus Found In The Brain, Shows Potential Connection To Epilepsy
The virus becomes a potential new target for treating a common form of childhood epilepsy Researchers at Shriner's Hospital Pediatric Research Center at the Temple University School of Medicine, and the University of Pennsylvania have evidence linking the human papillomavirus 16 (HPV16) - the most common cause of cervical cancer - to a common form of childhood epilepsy...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Among Female Smokers Risk Of Lung Cancer Death Has Risen Dramatically In Recent Decades
Female smokers have a much greater risk of death from lung cancer and chronic obstructive lung disease (COLD) in recent years than did female smokers 20 or 40 years ago, reflecting changes in smoking behavior according to a Special Article published in this week's New England Journal of Medicine (NEJM). The increase in risk of death from lung cancer and COLD in female smokers has been large enough to completely offset improvements in longevity from medical advances that have reduced death rates in the rest of the population over the last 50 years...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news

Mastectomy drug trial tests begin
New treatment for breast cancer patients could be rolled out nationwide if a study in Cornwall proves successful.
Source: BBC News | Health | UK Edition - January 25, 2013 Category: Consumer Health News Source Type: news

Dr. Marcus Neubauer joins McKesson Specialty Health as Medical Director, Oncology Services
Source: McKesson News - January 25, 2013 Category: Information Technology Source Type: news

Avastin Wins FDA Approval For Colorectal Cancer Treatment
The U.S. Food and Drug Administration (FDA) has approved use of Roche's Avastin for patients with colorectal cancer that has gotten worse despite treatment with the medication. This new approval will permit patients who were already treated once with Avastin plus chemotherapy to be treated again with Avastin in combination with a different chemotherapy regimen. Hal Barron, MD, Roche's Chief Medical Officer and Head of Global Product Development said: "The majority of people diagnosed with metastatic colorectal cancer receive Avastin plus chemotherapy as their initial treatment...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Roche's Avastin Approved For Colon Cancer Treatment By FDA
The U.S. Food and Drug Administration (FDA) has approved use of Roche's Avastin for patients with colorectal cancer that has gotten worse despite treatment with the medication. This new approval will permit patients who were already treated once with Avastin plus chemotherapy to be treated again with Avastin in combination with a different chemotherapy regimen. Hal Barron, MD, Roche's Chief Medical Officer and Head of Global Product Development said: "The majority of people diagnosed with metastatic colorectal cancer receive Avastin plus chemotherapy as their initial treatment...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

New Method Predicts Brain Cancer Outcome And Quickly Shows If Therapy Is Effective
The critical question shortly after a brain cancer patient starts treatment: how well is it working? But there hasn't been a good way to gauge that. Now Northwestern Medicine researchers have developed a new method -- similar to forecasting storms with computer models -- to predict an individual patient's brain tumor growth. This growth forecast will enable physicians to rapidly identify how well the tumor is responding to a particular therapy. The approach allows a quick pivot to a new therapy in a critical time window if the current one isn't effective...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Natural Switch Discovered That Controls Spread Of Breast Cancer Cells
With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body's inflammatory response and how malignant breast cancer cells use the bloodstream to spread.* Pro-inflammatory signaling molecules in blood called cytokines constitute a "switch" that induces the mechanism by which breast cancer cells "roll" and adhere to the blood vessel surface. The cancer cells eventually stick to the vessel and infiltrate it. The laboratory of Michael R...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Promising Prognostic Marker Discovered For Aggressive Breast Cancer
A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer. Published in Science Translational Medicine, the study lays the early foundation for predicting which breast cancer patients may develop more aggressive disease and for designing more effective treatments...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Carcinogenic Fumes From Chinese E-Waste Site Increase Lung Cancer Risk In Local Residents
Residents living near an e-waste recycling site in China face elevated risks of lung cancer, according to a recent study co-authored by Oregon State University researchers. Electronic trash, such as cell phones, computers and TVs, is often collected in dumps in developing countries and crudely incinerated to recover precious metals, including silver, gold, palladium and copper. The process is often primitive, releasing fumes with a range of toxic substances, including polycyclic aromatic hydrocarbons, or PAHs, a group of more than 100 chemicals...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Lung Cancer Source Type: news

It's Never Too Late To Quit: Smoking Cessation At Time Of Diagnosis Leads To Greater Success For Cancer Patients
Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse. The study was published in a recent issue of the journal Cancer. "Cigarette smoking is responsible for 30 percent of all cancer-related mortalities," said study corresponding author Vani Nath Simmons, Ph.D., assistant member of the Health Outcomes and Behavior Program at Moffitt...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news

Mutant 'Drivers' Of Meningiomas Identified By Genomic Sequencing
Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report scientists from Dana-Farber Cancer Institute and the Broad Institute. Surgery and radiation currently are the only treatments for meningiomas - slow-growing, often benign tumors that develop in the membranes surrounding the brain. Meningiomas can grow dangerously large, however, causing seizures and limb weakness, and occasionally are fatal...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

Modification Of Circadian Rhythms For Potential Treatment Of Disorders
UC Irvine-led studies have revealed the cellular mechanism by which circadian rhythms - also known as the body clock - modify energy metabolism and also have identified novel compounds that control this action. The findings point to potential treatments for disorders triggered by circadian rhythm dysfunction, ranging from insomnia and obesity to diabetes and cancer. UC Irvine's Paolo Sassone-Corsi, one of the world's leading researchers on the genetics of circadian rhythms, led the studies and worked with international groups of scientists...
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

High fiber diet halts the progression and spread of prostate cancer
The sobering fact is that one in six men will be affected by prostate cancer at some point in their lifetime, as nearly a quarter of a million are diagnosed in the U.S. each year. Although many men can live a normal lifespan as long as the disease remains localized,...
Source: NaturalNews.com - January 25, 2013 Category: Consumer Health Advice Source Type: news

Breast cancer death rates drop for younger women, but not older ones
The rate of deaths attributable to breast cancer in Spain has dropped among young and middle-aged women since 1992, but has not decreased among elderly women, according to a study conducted by researchers from the Rey Juan Carlos University in Madrid and published in...
Source: NaturalNews.com - January 25, 2013 Category: Consumer Health Advice Source Type: news

Medical science continues to remain silent about milk thistle as a cancer remedy
Milk thistle, or silymarin, has been used as a natural herb to assist liver function for thousands of years. Well established as a liver herb in both alternative and scientific literature, milk thistle strengthens liver cell membranes, decreases "bad" cholesterol levels...
Source: NaturalNews.com - January 25, 2013 Category: Consumer Health Advice Source Type: news

Partnerships Can Fight Childhood Obesity in Tennessee (Opinion)
America has a weight problem — and I’m not simply referring to the few extra pounds many of us pick up over the holidays. According to the Centers for Disease Control and Prevention, nearly 70 percent of Americans are either overweight or obese, and our wide waistlines put us at greater risk for life-threatening health conditions such as heart disease, stroke, type 2 diabetes and several types of cancer. Unfortunately, Tennesseans fare worse than most.
Source: RWJF News Digest - Childhood Obesity - January 25, 2013 Category: Eating Disorders and Weight Management Source Type: news

Revealing DNA: Damages Related to Cancer
(Ivanhoe Newswire) – It is understood that damaged sections of DNA, often damaged during replication before cell division, may result in cancer. Now, for the first time researchers have pinpointed a particular class of DNA associated with B cell lymphoma, a form of blood cancer, named early replicating fragile sites (ERFSs).
Source: Medical Headlines From Ivanhoe.com - January 25, 2013 Category: Consumer Health News Source Type: news

Dietary intake of veg linked to lower risk of ER-negative breast cancer
But no association between veg intake and risk of overall breast cancerRelated items from OnMedicaDoubts cast on role of fruit and veg in staving off cancerBreast screening risks outweigh benefits says BaumA drink a day can increase breast cancer risk by 5%Women may be offered drug to prevent breast cancerStudy shows link between diet and breast cancer
Source: OnMedica Latest News - January 25, 2013 Category: UK Health Source Type: news

Folic acid not linked to cancer risk
Study confirms fortification doesn’t raise medium-term risk of any cancersRelated items from OnMedicaExposure to valproate in womb curbs child’s IQFish oil capsules don’t cut PNDBritons waste millions on needless dietary supplementsMultivitamins in low doses cut cancer ratesVitamin pills to help subfertile men
Source: OnMedica Latest News - January 25, 2013 Category: UK Health Source Type: news